Browse > Article

The Long-term Outcome and Predictors for Increased Survival after PDT for Hilar Cholangiocarcinoma  

Ahn, Ji-Ho (Department of Internal Medicine, Institute for Digestive Research, Soonchunhyang University College of Medicine)
Cheon, Young-Koog (Department of Internal Medicine, Institute for Digestive Research, Soonchunhyang University College of Medicine)
Cho, Young-Deok (Department of Internal Medicine, Institute for Digestive Research, Soonchunhyang University College of Medicine)
Choi, Hyun-Jong (Department of Internal Medicine, Institute for Digestive Research, Soonchunhyang University College of Medicine)
Moon, Jong-Ho (Department of Internal Medicine, Institute for Digestive Research, Soonchunhyang University College of Medicine)
Lee, Tae-Hoon (Department of Internal Medicine, Institute for Digestive Research, Soonchunhyang University College of Medicine)
Park, Sang-Heum (Department of Internal Medicine, Institute for Digestive Research, Soonchunhyang University College of Medicine)
Shim, Chan-Sup (Digestive Disease Center, Konkuk University College of Medicine)
Publication Information
Clinical Endoscopy / v.42, no.1, 2011 , pp. 6-10 More about this Journal
Abstract
Background/Aims: Photodynamic therapy (PDT) has a promising effect on nonresectable cholangiocarcinoma (CC) but its long term data is not yet available. This study examined the long term outcome and factors associated with increased survival after performing PDT for hilar cholangiocarcinoma. Methods: A list of 393 patients with a diagnosis of hilar CC was retrieved from the database of Soonchunhyang University Hospital (Seoul, Korea) and these patients were seen from January 1, 2001, to April 1, 2010. We retrospectively reviewed the records of 74 patients who underwent PDT in addition to biliary stenting with/without chemoradiation. Results: The median overall survival from the date of diagnosis to death or to the last follow-up was 11.7 months (range: 2.2~78.4). After performing PDT, a complete remission was observed in 1.3% (1/74) of the patients who had a superficial depth of tumor without lymph node involvement. On multivariate analysis using the Cox regression model, increasing the time to treatment after the diagnosis was a statistically significant predictor of shorter survival after PDT [Odds ratio: 3.25, 95% confidence interval (CI): 1.90~4.71, p=0.034]. Conclusions: Although PDT does not prevent progression of CC, it appears to control the cholestasis. The early treatment of PDT after the diagnosis showed a survival benefit for patients with advanced hilar CC.
Keywords
Hilar cholangiocarcinoma; Photodynamic therapy; Survival;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kremer B, Henne-Bruns D, Vogel I, Grimm H, Soehendra N. Impact of staging on treatment of biliary carcinoma. Endoscopy 1993;25:92-99.   DOI   ScienceOn
2 Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 1997;79:26-34.   DOI   ScienceOn
3 Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992;340:1488-1492.   DOI   ScienceOn
4 Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002;51(suppl 6):VI1-9.
5 Pitt HA, Nakeeb A, Abrams RA, et al. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg 1995;221:788-797.   DOI   ScienceOn
6 Berr F, Wiedmann M, Tannapfel A, et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 2000;31:291-298.   DOI   ScienceOn
7 Ortner ME, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003;125:1355-1363.   DOI   ScienceOn
8 Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinoma. Semin Liver Dis 1994;14:109-114.   DOI   ScienceOn
9 Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH. Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998;228:385-394.   DOI   ScienceOn
10 Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975;140:170-178.
11 Shim CS, Cheon YK, Cha SW, et al. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment. Endoscopy 2005;37:425-433.   DOI   ScienceOn
12 Cheon YK, Cho YD, Moon JH, et al. Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy. Am J Gastroenterol 2007;102:2164-2170.   DOI   ScienceOn
13 Molt P, Hopfan S, Watson RC, Botet JF, Brennan MF. Intraluminal radiation therapy in the management of malignant biliary obstruction. Cancer 1986;57:536-544.   DOI   ScienceOn
14 Bowling TE, Galbraith SM, Hatfield AR, Solano J, Spittle MF. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 1996;39:852-855.   DOI   ScienceOn
15 Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 2005;100:2426-2430.   DOI   ScienceOn
16 Valle J, Wasan H, Palmer DH, et al. ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010;362:1273-1281.   DOI   ScienceOn
17 Edell ES, Cortese DA. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992;102:1319-1322.   DOI   ScienceOn
18 Prasad GA, Wang KK, Baron TH, et al. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma. Clin Gastroenterol Hepatol 2007;5:743-748.   DOI   ScienceOn
19 Prout GR Jr, Lin CW, Benson R Jr, et al. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. N Engl J Med 1987;317:1251-1255.   DOI   ScienceOn